Gerresheimer AG (XTRA: GXI)
Health Care · Life Sciences Tools & Services · DE
€26.14
-6.71% today · -38.8% 1Y
Gerresheimer AG (XTRA: GXI) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.13B and employs 13,528 people.
Over the last twelve months the share price has lost 38.8%, trading between 14.83 and 46.72.
Tweenvest scores Gerresheimer AG across four factors: quality 66/100, value 66/100, growth 40/100. Its strongest factor is quality.
GXI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.13B
- Revenue (TTM)
- $2.69B
- P/E
- —
- EPS
- -9.27
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- €46.72
- 52-week low
- €14.83
- Avg volume (3M)
- —
- Shares outstanding
- 34.54M
- Employees
- 13,528
- Next earnings
- —
About Gerresheimer AG
Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its Plastics & Devices segment provides a variety of drug administration tools, such as inhalers, insulin pen systems, prefillable syringes, and diagnostic systems, for the pharmaceutical, biotech, diagnostics, and medical technology sectors. This division also manufactures plastic containers, closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and related accessories for solid, liquid, and ophthalmic applications, alongside bottles for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging products for the pharmaceutical and cosmetics industries, including infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; and miniature bottles for liquid food, spices, spirits, fragrances, deodorants, skincare, and wellness products. Lastly, the Advanced Technologies division focuses on developing intelligent drug delivery systems, like micro pumps, designed to enable the self-administration of medication for conditions such as Parkinson's disease or heart failure, serving its pharmaceutical and biotech clients.
- ISIN
- DE000A0LD6E6
- Founded
- 1864
- Listed since
- Jun 11, 2007
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $628.74 | -0.08% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.11 | -1.71% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF593.40 | +0.95% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.84B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.36B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.